Whitehawk Therapeutics, Inc.
WHWK
$4.27
-$0.13-2.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -666.28% | -519.37% | 67.66% | 74.68% | 84.08% |
| Total Depreciation and Amortization | -95.21% | -88.50% | -59.07% | -34.21% | -10.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.59% | 110.97% | -888.62% | -815.70% | -799.37% |
| Change in Net Operating Assets | 154.72% | -17.94% | 131.90% | 69.62% | -287.98% |
| Cash from Operations | 27.43% | -108.22% | -63.62% | -75.93% | -89.59% |
| Capital Expenditure | 100.00% | 99.93% | 66.63% | 67.69% | 71.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.07% | -100.07% | -- | -- | -- |
| Other Investing Activities | -1,717.67% | -377.99% | -430.81% | -613.11% | -83.17% |
| Cash from Investing | -168.85% | -164.68% | -52.82% | -47.97% | 350.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.48% | -99.95% | 68,445.89% | 48,026.92% | 47,568.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.77% | 81.79% | -35,531.25% | -11,076.47% | -4,353.13% |
| Cash from Financing | -13.28% | -100.87% | 72,496.92% | 60,029.94% | 115,026.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.55% | -210.97% | 125.82% | 119.16% | 483.87% |